1. Home
  2. HUBC vs ACXP Comparison

HUBC vs ACXP Comparison

Compare HUBC & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HUBC

Hub Cyber Security Ltd.

HOLD

Current Price

$0.76

Market Cap

6.6M

Sector

N/A

ML Signal

HOLD

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.57

Market Cap

6.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUBC
ACXP
Founded
2017
2017
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
6.6M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
HUBC
ACXP
Price
$0.76
$1.57
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$95.50
AVG Volume (30 Days)
352.1K
82.4K
Earning Date
05-01-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$1.33
52 Week High
$7.00
$8.34

Technical Indicators

Market Signals
Indicator
HUBC
ACXP
Relative Strength Index (RSI) 35.26 54.77
Support Level $0.11 $1.36
Resistance Level $1.16 $1.75
Average True Range (ATR) 0.11 0.08
MACD -0.03 0.02
Stochastic Oscillator 15.60 77.22

Price Performance

Historical Comparison
HUBC
ACXP

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in developing reliable quality assurance systems that support process and product enhancement and also operates in the industry of secured data fabric. The company serves various organizations and institutions operating in the security, electronics, aviation, telecommunications, and banking. The company has two operating segments: Product and Technology Segment and Professional Services Segment. The majority of revenue comes from the professional services segment, which provides data and cybersecurity and system security and reliability solutions and related services such as consulting, planning, integrating and ongoing servicing of cybersecurity, risk management, reliability and security projects and fully managed corporate cybersecurity services.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Share on Social Networks: